PALO ALTO, Calif., April 27, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will demonstrate its full range of radiation
Visitors to the Varian booth (No. 4000) will be able to learn more about the company's new HyperArc™* high-definition radiotherapy system, which exploits specific capabilities of the TrueBeam® and Edge™ platforms and is designed to deliver more compact radiation doses that may fully saturate a targeted tumor and "fall off" sharply outside the target zone, potentially minimizing dose to specific organs requiring more protection.
"This exciting new technology unlocks the potential of using highly non-coplanar treatment strategies to usher in a new era of precision in radiotherapy and radiosurgery for cancer patients," says Kolleen Kennedy, president of Varian's Oncology Systems group. "It is designed to automate and simplify sophisticated treatments such as Stereotactic Radiosurgery (SRS), and make them available to more cancer patients around the world."
Also on display at the Varian booth will be the company's TrueBeam® platform for radiotherapy and radiosurgery, along with the RapidArc® image-guided intensity-modulated radiotherapy system, as well as Varian's range of advanced brachytherapy software and hardware.
Varian will also exhibit recent additions to its powerful family of oncology software products, including the 360 Oncology™ care management platform, the first software system designed to integrate and coordinate key elements of cancer care so patients and their cancer teams can collaborate on achieving the best outcomes. 360 Oncology is designed to bring together in a single platform, radiation, medical and surgical oncology, social services, primary care physicians, as well as the patient, to facilitate true collaborative and coordinated care. Other software highlights include the latest versions of Varian's ARIA® oncology information and Eclipse™ treatment planning systems.
Additionally, the Varian booth will spotlight the company's ProBeam® system, a fully-integrated image-guided IMPT (intensity-modulated proton therapy) solution, which incorporates pencil-beam scanning technology to optimize the dose applied to every point within the area being treated. ProBeam has been selected to equip multiple proton therapy centers around the world, including several in Europe.
Varian is hosting an international oncology summit for customers to kick off its ESTRO activities on May 5th at the Hilton Vienna and other ESTRO events include a Varian lunch symposium on Sunday May 7th.
*Not available for sale in every territory
About Varian Medical SystemsVarian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people at sites around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Neil MadleVarian Medical Systems+44 7786 526068 [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/varian-spotlights-world-leading-systems-for-advanced-radiotherapy-radiosurgery-brachytherapy-and-proton-therapy-at-estro-36-300446986.html
SOURCE Varian Medical Systems
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All